AILERON SCHEDULE 13D

Company

Rein Therapeutics, Inc.

Filed

July 17, 2017

Accession Number

0001596770-17-000019

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →